Palumbo Wealth Management »

Taysha Gene Therapies shares owned by Palumbo Wealth Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Palumbo Wealth Management from 13F filings

Historical chart of Palumbo Wealth Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Palumbo Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Palumbo Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $515k 157k 3.27

More positions owned by Palumbo Wealth Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Apple (AAPL)
Amazon (AMZN)
Invesco Db Commdy Indx Trck Unit (DBC)
Microsoft Corporation (MSFT)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
NVIDIA Corporation (NVDA)
Waste Management (WM)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Costco Wholesale Corporation (COST)
Sprott Asset Management Physical Gold Tr (PHYS)
Visa Com Cl A (V)
Illinois Tool Works (ITW)

View all positions for Palumbo Wealth Management

Top funds holding Taysha Gene Therapies

Rtw Investments
RA Capital Management
venBio Select Advisor
Morgan Stanley
BlackRock
FMR
Goldman Sachs Group
Vanguard Group
Siren
Octagon Capital Advisors
Point72 Asset Management
State Street Corporation
Vestal Point Capital
Deerfield Management Company
Polar Capital Holdings

View all funds holding Taysha Gene Therapies